receptor agonist with moderate activity as a 5-HT3
antagonist. Has no affinity at 5-HT1
or dopamine D2
receptors. Potential gastrokinetic agent.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Synthesis of 2-piperazinybenzothiazole and 2-piperazinylbenzoxazole derivatives with 5-HT3 antagonist and 5-HT4 agonist properties.
Monge et al.
The citations listed below are publications that use Tocris products. Selected citations for 2-[1-(4-Piperonyl)piperazinyl]benzothiazole include:
Showing Results 1 - 1 of 1